Recent advances in the synthesis and activity of analogues of bistetrahydroisoquinoline alkaloids as antitumor agents

天然产物 化学 四氢异喹啉 药物发现 全合成 计算生物学 生化工程 立体化学 生物化学 生物 工程类
作者
Ju Guo
出处
期刊:European journal of medicinal chemistry [Elsevier BV]
卷期号:262: 115917-115917 被引量:10
标识
DOI:10.1016/j.ejmech.2023.115917
摘要

Ecteinascidin 743 (Et-743), also known by the trade name Yondelis®, is the pioneering marine natural product to be successfully developed as an antitumor drug. Moreover, it is the first tetrahydroisoquinoline natural product used clinically for antitumor therapy since Kluepfel, a Canadian scientist, discovered the tetrahydroisoquinoline alkaloid (THIQ) naphthyridinomycin in 1974. Currently, almost a hundred natural products of bistetrahydroisoquinoline type have been reported. Majority of these bistetrahydroisoquinoline alkaloids exhibit diverse pharmacological activities, with some family members portraying potent antitumor activities such as Ecteinascidins, Renieramycins, Saframycins, Jorumycins, among others. Due to the unique chemical structure and exceptional biological activity of these natural alkaloids, coupled with their scarcity in nature, research seeking to provide material basis for further bioactivity research through total synthesis and obtaining compound leads with medicinal value through structural modification, remains a hot topic in the field of antitumor drug R&D. Despite the numerous reviews on the total synthesis of bistetrahydroisoquinoline natural products, comprehensive reviews on their structural modification are apparently scarce. Moreover, structural modification of bioactive natural products to acquire lead compounds with improved pharmaceutical characteristics, is a crucial approach for innovative drug discovery. This paper presents an up-to-date review of both structural modification and activity of bistetrahydroisoquinoline natural products. It highlights how such alkaloids can be used as antitumor lead compounds through careful chemical modifications. This review offers valuable scientific references for pharmaceutical chemists engaged in developing novel antitumor agents based on such alkaloid modifications, as well as those with such a goal in future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
搜集达人的应助被lll采纳,获得10
1秒前
1秒前
荼蘼发布了新的文献求助10
2秒前
钟美蒂的阴灵完成签到,获得积分10
2秒前
bkagyin的应助被哭泣的芷容采纳,获得10
3秒前
深情安青的应助被FGGFGGU采纳,获得10
3秒前
3秒前
在水一方的应助被lm采纳,获得10
4秒前
4秒前
秀丽的冰萍完成签到,获得积分10
4秒前
冰_完成签到 ,获得积分10
5秒前
VIOLET发布了新的文献求助10
5秒前
俏皮的钻石完成签到 ,获得积分10
6秒前
6秒前
6秒前
fantasy的应助被GamAooL采纳,获得10
6秒前
海岸线发布了新的文献求助10
7秒前
7秒前
英姑的应助被山复尔尔采纳,获得10
7秒前
小二郎的应助被sttise采纳,获得10
7秒前
合适高跟鞋完成签到 ,获得积分20
8秒前
wf完成签到,获得积分10
9秒前
哇哈哈发布了新的文献求助10
9秒前
哈基咪完成签到 ,获得积分10
10秒前
10秒前
10秒前
12发布了新的文献求助30
10秒前
11秒前
yhr发布了新的文献求助10
11秒前
小蘑菇的应助被LIU采纳,获得10
12秒前
12秒前
荼蘼发布了新的文献求助30
12秒前
12秒前
13秒前
浮云发布了新的文献求助10
13秒前
呆萌白薇完成签到,获得积分10
13秒前
14秒前
14秒前
Lio发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241